T. Strobel et al., BAX ENHANCES PACLITAXEL-INDUCED APOPTOSIS THROUGH A P53-INDEPENDENT PATHWAY, Proceedings of the National Academy of Sciences of the United Statesof America, 93(24), 1996, pp. 14094-14099
To investigate the role of BAX in chemotherapy-induced apoptosis, we t
ransfected the SW626 human ovarian cancer cell line, which lacks funct
ional p53, with a cDNA encoding for murine BAX. Immunoblotting reveale
d that BAX transfectants expressed a mean of 10-fold increased levels
of BAX compared with neo-transfected control clones, with similar leve
ls of BCL-2 and BCL-X(L). The cytotoxicity of paclitaxel, vincristine,
and doxorubicin was significantly enhanced in BAX transfectants compa
red with control clones, whereas the cytotoxicity profile of carboplat
in, etoposide, and hydroxyurea was unchanged, Increased paclitaxel-ind
uced cytotoxicity of BAX clones was associated with enhanced apoptosis
, as assessed by morphologic and flow cytometric criteria, These data
suggest that sufficient levels of BAX may bypass the need for upstream
molecules such as p53 in the process of chemotherapy-induced apoptosi
s.